THE EUROPEAN Medicines Agency (EMEA) has released a guideline on developing, producing, characterising and specifying monoclonal antibodies and related products -http://www.emea.europa.eu/pdfs/human/bwp/15765307enfin.pdf;
*EMEA has also released a draft policy on obtaining practical access to its documents - http://www.emea.europa.eu/pdfs/general/direct/11019606en.pdf;
*This includes a document on accessing its adverse reactions database EudraVigilance -http://www.emea.europa.eu/pdfs/human/phv/18743906en.pdf.
Other ...

Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.